MabThera (rituximab) 500 mg, Roche, Germany, original Order MabThera (rituximab) 500 mg, Roche, Germany, original. Medicine delivery from Europe within 4-5 days with storage conditions maintained. Payment on delivery. Contact +380996042415.
Delivery methods
- We can ship by mail to any European country with a delivery time of 8-10 days. Only medications that do not require refrigeration possible shipping. Shipping costs are 40-50 euro, depending on the destination country.
Delivery time
- Originator medicines: 8-10 days
- Generic medicines: 8-10 days
Payment methods
- Bank transfer to the settlement account after receiving the order
Interchangeable drugs with the same active substance:
- Mabthera
- Reditux
- Rituxim
- Acellbia
Indications.
- MabThera®is indicated for adults in the following cases:
- non-Hodgkin's lymphoma
- Monotherapy for patients with follicular lymphoma Stage III-IV, resistant to chemotherapy or are in the stage of second or subsequent relapses after chemotherapy.
- Treatment of CD20-positive diffuse large B-cell non-Hodgkin lymphoma in combination with chemotherapy according to the CHOP regimen (cyclophosphamide, doxorubicin, vincristine, prednisolone).
- Earlier treatment untreated follicular lymphoma stage III-IV in combination with chemotherapy.
- Maintenance therapy of follicular lymphomas after receiving a response to induction therapy.
- chronic lymphocytic leukemia
- Treatment of previously untreated and recurrent / refractory chronic lymphocytic leukemia in combination with chemotherapy. There are only limited data regarding the effectiveness and safety of use in patients previously treated with monoclonal antibodies, including MabThera®, or in patients refractory to previous treatment with MabThera®plus chemotherapy.
- rheumatoid arthritis
- Treatment of severe rheumatoid arthritis (active form) in adults in combination with methotrexate when treatment with other disease-modifying antirheumatic drugs (DMARDs) is ineffective or intolerant, including treatment with one or more tumor necrosis factor inhibitors.
- When used in combination with methotrexate Mabthera®reduces the rate of progression of destructive changes in joints according to X-ray data and improves physical function.
- Granulomatosis with polyangiitis and microscopic polyangiitis
- Treatment of severe forms of active granulomatosis with polyangiitis (Wegener's granulomatosis) and microscopic polyangiitis in combination with GCS to induce remission in adult patients
- Trade name:MabThera
- Chemical name:Rituximab
- Dosage:500 mg
- Quantity:1
- Dosage form:Ampoule
- Manufacturer:Roche, Germany
No reviews yet
